Tag: ACTRIMS
Clene Nanomedicine Presents Updated Interim Data from Phase 2 Multiple Sclerosis...
Blinded interim data from VISIONARY-MS continue to support the potential of CNM-Au8 to drive meaningful neurological functional improvements in MS patientsInterim REPAIR-MS results...